1 directorName after signing inVisible after signing in
Documentsfilings and deeds
29-08-202629 days late
2025micro format
Gross margin from €52,203 to €133,551Result from €35,179 to €92,543Dividend €833Equity from €39,320 to €131,030Debts from €8,812 to €18,888Cash from €42,950 to €136,931
Higher solvency than 80% of companies in human health. The sector median is 63.0%, over 21,397 companies.
2025 accounts filed 29 days after the deadline
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 39,327 companies had the same profile as Jolien Clijmans has now. Each dot stands for 99 companies, two years later.
95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
Micro
2 to 5 years old
solvency 30% or more
a profit of 5% of the balance sheet or more
Test of the method
The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.4%
0.5%
3
0.6%
0.6%
4
0.7%
0.8%
5
0.9%
1.0%
6
1.4%
1.6%
7
1.7%
1.8%
8
1.9%
2.0%
9
3.1%
3.3%
10
5.9%
6.4%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,327 companies, not a prediction for Jolien Clijmans. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1007639562
Incorporation
Founding capital of €5,000, 100 shares · Founded by Name hiddenVisible after signing in (partner and founder) · Hidden nameVisible after signing in appointed as director · published on 29-03-2024 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as Jolien Clijmans: general medical practice (NACE 86210). They are comparable in size and age: total assets between €138,000 and €152,000, founded between 2023 and 2024.
Jolien Clijmans has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €131,030 and a net result of €92,543.
Its solvency ranks better than 80% of 21,397 sector peers (NACE 86) in financial year 2025.
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Jolien Clijmans?
Jolien Clijmans is a private limited company (BV).
When was Jolien Clijmans founded?
Jolien Clijmans was founded on 27-03-2024.
Is Jolien Clijmans still active?
Yes, Jolien Clijmans is an active enterprise in the KBO register.
What is the turnover of Jolien Clijmans?
The turnover in financial year 2025 is about €240,000. This figure is estimated from the gross margin of €133,551 and 30 comparable companies (NACE 86210). It probably lies between €190,000 and €300,000.Financials
Is Jolien Clijmans profitable?
In financial year 2025, Jolien Clijmans made a profit of €92,543.
Where can I find the annual accounts of Jolien Clijmans?
Jolien Clijmans filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Jolien Clijmans due?
Jolien Clijmans must file the annual accounts for financial year 2026 by 31-07-2027.Timeline